​

OnKure Therapeutics Ownership | Who Owns OnKure Therapeutics?

OverviewFinancialsChart

OnKure Therapeutics Ownership Summary

OnKure Therapeutics is owned by 79.77% institutional investors, 1.45% insiders, and 18.78% retail investors. Shay capital is the largest institutional shareholder, holding 5.79% of OKUR shares.

OKUR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOnKure Therapeutics79.77%1.45%18.78%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.68%11.10%-217.78%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Shay capital782.05K5.79%$1.87M
Cantor fitzgerald, l. p.669.54K4.96%$1.60M
Highbridge capital management663.61K4.91%$1.59M
Vestal point capital, lp635.00K4.70%$1.52M
Blackrock funding, inc. /de564.80K4.18%$1.35M
Stepstone group lp491.94K3.64%$1.18M
Nea management company478.55K3.54%$1.14M
Affinity asset advisors347.99K2.58%$831.70K
Carlyle group269.89K2.00%$642.35K
Deep track capital, lp180.51K1.34%$431.42K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stepstone group lp491.94K2.33%$1.18M
Shay capital782.05K0.21%$1.87M
Affinity asset advisors347.99K0.11%$831.70K
Aldebaran capital44.17K0.10%$105.57K
Prosight management, lp159.69K0.09%$381.66K
Nea management company478.55K0.09%$1.14M
Vestal point capital, lp635.00K0.08%$1.52M
Highbridge capital management663.61K0.06%$1.59M
Aisling capital management lp88.61K0.06%$211.77K
Sphera funds management60.45K0.03%$144.49K

Top Buyers

HolderShares% AssetsChange
Shay capital782.05K0.21%631.01K
Cantor fitzgerald, l. p.669.54K0.03%538.84K
Blackrock funding, inc. /de564.80K-475.82K
Highbridge capital management663.61K0.06%224.81K
Bailard14.24K0.00%14.24K

Top Sellers

HolderShares% AssetsChange
Cormorant asset management, lp---1.84M
Perceptive advisors---1.00M
Samsara biocapital---824.15K
Deep track capital, lp180.51K0.01%-343.48K
Ikarian capital---253.75K

New Positions

HolderShares% AssetsChangeValue
Bailard14.24K0.00%14.24K$34.03K
Trust co of toledo na /oh/136.00-136.00$325.00

Sold Out

HolderChange
Qube research-18.66K
Boothbay fund management-78.02K
Ikarian capital-253.75K
Samsara biocapital-824.15K
Perceptive advisors-1.00M

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025484.35%10,776,588-9.78%791.01%23-50.00%13-
Mar 31, 20252-710,559-5-2---

Recent Insider Transactions

DateNameRoleActivityValue
Jun 23, 2025Saccomano Nicholas A President and CEOSell$209.81
Jun 23, 2025Leverone Jason A. Chief Financial OfficerSell$722.41
May 15, 2025Cormorant Asset Management, LP Former 10% OwnerSell$3.36M
May 15, 2025ACORN BIOVENTURES, L.P.-Buy$2.09M
May 15, 2025ACORN BIOVENTURES, L.P.-Buy$500.00K

Insider Transactions Trends

DateBuySell
2025 Q228
2025 Q1--
2024 Q4--

OKUR Ownership FAQ

Who Owns OnKure Therapeutics?

OnKure Therapeutics shareholders are primarily institutional investors at 79.77%, followed by 1.45% insiders and 18.78% retail investors. The average institutional ownership in OnKure Therapeutics's industry, Biotech Stocks , is 306.68%, which OnKure Therapeutics falls below.

Who owns the most shares of OnKure Therapeutics?

OnKure Therapeutics’s largest shareholders are Shay capital (782.05K shares, 5.79%), Cantor fitzgerald, l. p. (669.54K shares, 4.96%), and Highbridge capital management (663.61K shares, 4.91%). Together, they hold 15.66% of OnKure Therapeutics’s total shares outstanding.

Does Blackrock own OnKure Therapeutics?

BlackRock is not among the top 10 institutional shareholders of OnKure Therapeutics.

Who is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested?

Stepstone group lp is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.33% of its assets in 491.94K OnKure Therapeutics shares, valued at 1.18M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools